Chapter

A Rapid-ACCE review of <i>CYP2C9</i> and <i>VKORC1</i> allele testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding

Monica R. McClain, Glenn E. Palomaki, Margaret Piper and James E. Haddow

in Human Genome Epidemiology, 2nd Edition

Published in print December 2009 | ISBN: 9780195398441
Published online May 2010 | e-ISBN: 9780199776023 | DOI: http://dx.doi.org/10.1093/acprof:oso/9780195398441.003.0031
 							A Rapid-ACCE review of CYP2C9 and VKORC1 allele testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding

More Like This

Show all results sharing this subject:

  • Public Health and Epidemiology

GO

Show Summary Details

Preview

This chapter describes the results from a Rapid-ACCE review (Analytic validity, Clinical validity, Clinical utility, and Ethical, legal, and social implications), designed to facilitate the transition of genetic tests from investigational settings to clinical and public health practice. The ACCE model is composed of a standard set of 44 questions, and builds on the methodologies and terminology introduced by the Secretary's Advisory Committee on Genetic Testing. In this review, the genetic test is CYP2C9 and VKORC1 genotyping, the disorder is serious bleeding, and the clinical scenario is adults at elevated risk for thrombotic events who are candidates for warfarin. These two genes are responsible for much of the observed differences in drug metabolism between individuals.

Keywords: Rapid-ACCE review; genetic tests; public health practice; CYP2C9; VKORC1; warfarin; serious bleeding; thrombotic events

Chapter.  7766 words.  Illustrated.

Subjects: Public Health and Epidemiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.